written on 08.04.2014
Tags:
,

Teva entreats SCOTUS to block Copaxone generics till patent case wraps

TAGS: ,

Teva Pharmaceutical Industries has finally convinced the Supreme Court to hear its Copaxone patent appeal. But the high court may not hand down a decision till June 2015–and generic versions of the company's top moneymaker are on their way as soon as next month.

Latest Report